(Q41611097)

5 October 2017

1 reference

title

Clinical studies of cerebral blood flow in Alzheimer's disease (English)

1 reference

5 October 2017

0 references

0 references

Jagust WJ

1

1 reference

5 October 2017

Eberling JL

2

1 reference

5 October 2017

Reed BR

3

1 reference

5 October 2017

Mathis CA

4

1 reference

5 October 2017

Budinger TF

5

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

Annals of the New York Academy of Sciences

5 October 2017

published in

1 reference

5 October 2017

volume

826

1 reference

5 October 2017

page(s)

254-262

1 reference

Positron emission tomography in Alzheimer's disease

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Reduced temporal lobe blood flow in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Cognitive correlates of regional cerebral blood flow in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

The influence of age, anesthesia and cerebral arteriosclerosis on cerebral vascular activity to CO2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

Diminished glucose transport in Alzheimer's disease: dynamic PET studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48477.X

10.1111/J.1749-6632.1997.TB48477.X

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference